DDI-DrugBank.d717.s0 >> Mitotane has been reported to accelerate the metabolism of warfarin by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for warfarin. >> 0-7,59-66,175-182
DDI-DrugBank.d717.s1 >> Therefore, physicians should closely monitor patients for a change in anticoagulant dosage requirements when administering Mitotane to patients on coumarin-type anticoagulants. >> 70-82,123-130,147-174
DDI-DrugBank.d717.s2 >> In addition, Mitotane should be given with caution to patients receiving other drugs susceptible to the influence of hepatic enzyme induction. >> 13-20
